Up-regulation of type 1 plasminogen activator inhibitor messenger RNA with thrombotic changes in renal grafts.
Small vessel thrombosis is a prominent feature in kidneys undergoing vascular rejection. Type I and type 2 plasminogen activator inhibitors (PAI-1 and PAI-2, respectively) are known to mediate thrombosis. To examine the potential role of PAI-1 and PAI-2 in the mediation of vascular injury, the relationship and the time course of gene expression of PAI-1 and PAI-2 with the thrombotic changes in renal grafts were investigated in an unmodified rejection model in rats. Orthotopic renal transplantation was performed from Lewis to dark agouti (DA) rats and from DA to DA isografts; untreated normal rat kidneys were used as controls. The rats were killed on days 1-9 posttransplantation (n=18 in each allograft and isograft group). The grafts were analyzed by histopathology, in situ mRNA hybridization and Northern blot methods. The results show that PAM mRNA was first detected at day 4, when the thrombotic changes in the grafts were first seen, and that this relationship persisted during the time course observed to day 9. There was no detectable PAI-1 mRNA in the control groups and no PAI-2 in either group. In situ hybridization showed that PAI-1 positive cells were predominantly located in the cortical interstitium, consistent with the distribution of interstitial microthrombi. These results provide experimental evidence that the thrombotic changes in rejecting allografts are associated with the up-regulation of PAI-1 in the donor tissue, whereas PAI-2, from our results, does not seem to influence these changes. The data are consistent with a role for PAI-1 in the pathogenesis of vascular rejection.
Wang
Y
Y
Histopathology Department, Paediatric Research Unit, United Medical and Dental School of Guy's and St. Thomas' Hospital, Guy's Campus, London, United Kingdom.
Pratt
J R
JR
Tam
F W
FW
Hartley
B
B
Wolff
J A
JA
Olavesen
M G
MG
Sacks
S H
SH
D000818:Animals; D001483:Base Sequence; D015152:Blotting, Northern; D005786:Gene Expression Regulation; D006084:Graft Rejection; D017403:In Situ Hybridization; D016030:Kidney Transplantation / Q000009:adverse effects*; D008969:Molecular Sequence Data; D017395:Plasminogen Activator Inhibitor 1 / Q000235:genetics*; D012333:RNA, Messenger / Q000032:analysis*; D051381:Rats; D011917:Rats, Inbred Lew; D013927:Thrombosis / Q000378:metabolism*; D014184:Transplantation, Homologous; D015854:Up-Regulation
D017395:Plasminogen Activator Inhibitor 1; D012333:RNA, Messenger